Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MK2 and Fas Receptor Contribute to the Severity of CNS Demyelination.
[Factors associated to the work situation of patients with multiple sclerosis].
Paroxysmal dysarthria-ataxia in remitting-relapsing Bickerstaff's-like encephalitis.
Cloning, sequencing, expression and function of a cDNA encoding a receptor for the opioid growth factor, [Met(5)]enkephalin.
Functional electrical stimulation as a component of activity-based restorative therapy may preserve function in persons with multiple sclerosis.
Thrombotic processes in multiple sclerosis as manifestation of innate immune activation.
Dimethyl fumarate for treating relapsing multiple sclerosis.
The level of viral infection of antigen-presenting cells is critical for the development of TMEV-induced demyelinating disease.
Activation Status of Human Microglia Is Dependent on Lesion Formation Stage and Remyelination in Multiple Sclerosis.
Long term cardiac safety and tolerability of Fingolimod in Multiple Sclerosis: A post-marketing study.
Carer quality of life and experiences of health services: a cross-sectional survey across three neurological conditions.
Longitudinal changes in quality of life and related psychosocial variables in australians with multiple sclerosis.
The "central vein sign": is there a place for susceptibility weighted imaging in possible multiple sclerosis?
Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
Study boosts vitamin D-multiple sclerosis link.
Cord blood mononuclear cells prevent neuronal apoptosis in response to perinatal asphyxia in the newborn lamb.
Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis.
[Clinical outcome of the hyperacute form of acute disseminated encephalomyelitis.]
Alterations in the cholinesterase and adenosine deaminase activities and inflammation biomarker levels in patients with multiple sclerosis.
Energy crisis: The role of oxidative phosphorylation in acute inflammation and sepsis.
The pathological and physiological roles of IL-6 amplifier activation.
Sex Chromosome Complement Influences Functional Callosal Myelination.
Relapsing MS patients more satisfied with Novartis oral drug Gilenya(TM) than standard injectable therapies, according to new study results at CMSC
Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers.
A method for estimating and removing streaking artifacts in quantitative susceptibility mapping.
Pages
« first
‹ previous
…
610
611
612
613
614
615
616
617
618
…
next ›
last »